Dudediligence.

Enliven Therapeutics, Inc

ELVNNASDAQ · Pharmaceutical Preparations
Write an idea

Filings

Newest first

The annual , the quarterly and the filed between them when something material happens.

  1. Aug 510-QQuarterly report
  2. Aug 58-KResults of operations2.029.01
  3. Jun 128-KMaterial agreement and Regulation FD disclosure1.017.019.01
  4. Jun 12424B5Prospectus for an offering
  5. Jun 11424B5Prospectus for an offering
  6. Jun 118-KRegulation FD disclosure and other events7.018.019.01
  7. Jun 98-KBylaws or fiscal year changed and shareholder vote5.035.079.01
  8. May 710-QQuarterly report
  9. May 78-KResults of operations2.029.01
  10. Mar 310-KAnnual report
  11. Mar 38-KResults of operations2.029.01
  12. Jan 78-KOfficer or director change5.029.01
  13. Dec 11, 20258-KOfficer or director change and Regulation FD disclosure5.027.019.01
  14. Nov 13, 20258-K/AResults of operations (amended)2.029.01
  15. Nov 12, 202510-QQuarterly report
  16. Nov 12, 20258-KResults of operations2.029.01
  17. Aug 13, 202510-QQuarterly report